Expert Talk with Dr. Aviv Regev
Monday, March 1, 2021, 2:00 PM - 3:00 PM EST
The New York Academy of Sciences
Join us on March 1st, 2021 at 2pm EST to hear from Dr. Aviv Regev, Ph.D. Dr. Regev was recently chosen as the winner of The Foundation for the National Institutes of Health’s (FNIH) 2020 Lurie Prize in Biomedical Sciences. In this talk, Dr. Regev will share her personal journey and experience becoming a scientist, including how she has worked with her mentors and why pursuing a career in STEM is vital to today's world. She will share her exciting research in the field of single-cell genomics and the future of understanding biology and disease. Her presentation will be followed by an audience Q&A. We hope you will join us!
More about Dr. Regev:
Aviv Regev joined Genentech in August 2020 as Executive Vice President, Genentech Research and Early Development. In this role, she is responsible for the management of all aspects of gRED’s drug discovery and drug development activities. In addition, she is a member of the Genentech Executive Committee and a member of the expanded Corporate Executive Committee for Roche.
Prior to Genentech, Regev served as Chair of the Faculty, Core Institute Member, founding director of the Klarman Cell Observatory, and member of the Executive Leadership Team of the Broad Institute of MIT and Harvard, as well as Professor of Biology at MIT and Investigator at the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas.
Regev has served on multiple corporate advisory, scientific advisory, and journal editorial boards, including the advisory committee to the National Human Genome Research Institute at the National Institutes of Health.
Regev is a leader in deciphering molecular circuits that govern cells, tissues and organs in health and their malfunction in disease. Her lab has pioneered foundational experimental and computational methods in single-cell genomics, working toward greater understanding of the function of cells and tissues in health and disease, including autoimmune disease, inflammation and cancer. She is a member of the National Academy of Sciences and a Fellow of the International Society of Computational Biology. In 2020, she was the recipient of the Lurie Prize in Biomedical Sciences, Massachusetts General Hospital’s Jonathan Kraft Prize, and the European Society of Human Genetics’ Mendel Award.
Regev has a Ph.D. in computational biology and a Master of Science from Tel Aviv University. She lives in the San Francisco Bay Area with her husband and two children.